Papers
4
Total Citations
52
H-Index
3
About
Dr. Kosuke Mizutani is a pioneering urologic surgeon and researcher whose work bridges advanced robotic surgery and the molecular genetics of kidney cancer. His primary research areas include robot-assisted radical cystectomy for muscle-invasive bladder cancer and the genomic mechanisms underlying multifocal clear cell renal cell carcinoma (ccRCC). Dr. Mizutani’s major contributions center on refining minimally invasive surgical techniques: his 2019 paper on robot-assisted radical cystectomy with intracorporeal urinary diversion (38 citations) has become a key reference for improving patient outcomes and reducing recovery times. He also introduced a novel technique for totally intracorporeal ileal conduit construction, advancing the feasibility of fully robotic urinary diversion. In the realm of cancer genetics, his 2022 study (6 citations) revealed how derivative chromosome 3 loss from t(3;6)(q12;q14) followed by differential *VHL* mutations drives multifocal ccRCC, offering new insights into tumor heterogeneity and potential therapeutic targets. Notably, Dr. Mizutani has also applied his engineering mindset beyond medicine, co-developing an automatic shelf system for convenience stores in collaboration with collaborative robots—showcasing his versatility. With a growing citation impact and a unique blend of clinical innovation and basic science, Dr. Mizutani is shaping the future of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4